131i-tm-601
Animal productexperimental
Clinical trial activity
6 trials · 23 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2002 (NCT00040573)
Timeline
Indications
Studied for
- Astrocytoma · Phase 2
- Brain Neoplasms · Phase 1/Phase 2
- Breast Neoplasms · Phase 1
- Carcinoma, Non-Small-Cell Lung · Phase 1
- Colorectal Neoplasms · Phase 1
- Glioblastoma · Phase 2
- Glioma · Phase 2
- Gliosarcoma · Phase 2
- Melanoma · Phase 1/Phase 2
- Neoplasms · Phase 1
- Oligodendroglioma · Phase 1/Phase 2
- Pancreatic Neoplasms · Phase 1
- Prostatic Neoplasms · Phase 1
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 131i-tm-601
- 131i-tm-601
- 131i-tm-601
- chlorotoxin
- tm 601
- tm-601
- tm-601
- tm-601
- tm601 peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00733798 | Phase 1/Phase 2 (Phase 2) | Aug 11, 2008 | Mary Crowley Cancer Center, Mercy Health, Grand Rapids, New York University, TransMolecular |
| NCT00683761 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2008 | Baylor University, Cedars-Sinai Medical Center, Columbia University, Cornell University, Emory University, Harvard University, Johns Hopkins University, Medical College of Wisconsin, Northwestern University, TransMolecular, Tufts University, University of Alabama, Birmingham, University of Chicago, University of Rochester, University of South Florida, University of Virginia, University of Washington, Vanderbilt University |
| NCT00591058 | Phase 1 | Feb 1, 2008 | Cedars-Sinai Medical Center, Columbia University, Northwestern University, TransMolecular, University of Alabama, Birmingham, University of Washington, Wake Forest University, Washington University in St. Louis |
| NCT00379132 | Phase 1 | Aug 1, 2006 | Mary Crowley Cancer Center, Mercy Health, Grand Rapids, Northwestern University, TransMolecular, Tufts University, University of Alabama, Birmingham, University of Chicago |
| NCT00114309 | Phase 2 | Nov 1, 2004 | TransMolecular, University of Alabama, Birmingham |
| NCT00040573 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2002 | TransMolecular |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (23)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TransMolecular | For profit | 6 | 6 | 2 | 2002 |
| University of Alabama, Birmingham | Academic/Hospital | 4 | 0 | 2 | 2004 |
| Northwestern University | Academic/Hospital | 3 | 0 | 2 | 2006 |
| Cedars-Sinai Medical Center | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Columbia University | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Mary Crowley Cancer Center | Academic/Hospital | 2 | 0 | 2 | 2006 |
| Mercy Health, Grand Rapids | Academic/Hospital | 2 | 0 | 2 | 2006 |
| Tufts University | Academic/Hospital | 2 | 0 | 2 | 2006 |
| University of Chicago | Academic/Hospital | 2 | 0 | 2 | 2006 |
| University of Washington | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Medical College of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2008 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of South Florida | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Virginia | Academic/Hospital | 1 | 0 | 1 | 2008 |
23 organizations
Page 1 / 2